Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products

Biologicals : Journal of the International Association of Biological Standardization
Takao HayakawaPierrette Zorzi-Morre

Abstract

The regulation of human cell therapy products is a key factor in their development and use to treat human diseases. In that regard, there is a recognized need for a global effort to develop a set of common principles that may serve to facilitate a convergence of regulatory approaches to ensure the smooth and efficient evaluation of products. This conference, with experts from regulatory agencies, industry, and academia, contributed to the process of developing such a document. Elements that could form a minimum consensus package of requirements for evaluating human cell therapy products were the overall focus of the conference. The important regulatory considerations that are unique to human cell therapy products were highlighted. Sessions addressed specific points that are different from those of traditional biological/biotechnological protein products. Panel discussions complemented the presentations. The conference concluded that most of the current regulatory framework is appropriate for cell therapy, but there are some areas where the application of the requirements for traditional biologicals is inappropriate. In addition, it was agreed that there is a need for international consensus on core regulatory elements, and that...Continue Reading

References

Sep 21, 2011·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Adrian F Bristow
Aug 21, 2012·Biologicals : Journal of the International Association of Biological Standardization·Ivana KnezevicDavid Bramley
Feb 16, 2013·Biomaterials·Kazuo YanoMasayuki Yamato
Nov 19, 2013·Regenerative Medicine·Matthew D LiTania Bubela
Jul 30, 2014·Cytotherapy·Christopher A Bravery, Anna French
Dec 20, 2014·Biologicals : Journal of the International Association of Biological Standardization·Ken KonoYoji Sato
Jun 9, 2015·Molecular Therapy. Methods & Clinical Development·Natsumi WatanabeMasayuki Yamato

❮ Previous
Next ❯

Citations

Jul 28, 2016·Biologicals : Journal of the International Association of Biological Standardization·Takao HayakawaStephen Wicks
Jun 27, 2018·Journal of Biosocial Science·Basant Kumar Panda, Sanjay K Mohanty
Jun 27, 2018·Pharmaceutical Research·James W McBlaneMichaela Sharpe

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.